Clinical Trials Directory

Trials / Completed

CompletedNCT05274464

A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach

A Recurrence Nomogram to Guide Surveillance Strategies After the Resection of Hepatoid Adenocarcinoma of the Stomach: a China Hepatoid Adenocarcinoma of the Stomach Study Group Database Study

Status
Completed
Phase
Study type
Observational
Enrollment
261 (actual)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study aims to develop a nomogram to predict postoperative recurrence of HAS and guide individually tailored surveillance strategies.

Detailed description

Patients were included from the China Hepatoid Adenocarcinoma of the Stomach Study Group (China-HASSG) database, which comprises 14 tertiary referral centers. All the patients who had undergone complete resection of a primary HAS between April 2004 and December 2019 were included. First, univariate analysis was performed in Cox regression to identify the risk factors associated with RFS. Next, variables with P\< 0.05 in univariable analysis were included in the multivariable model, and the forward likelihood ratio method was used for analysis to confirm the independent prognostic factors associated with RFS. Finally, based on the results of multivariable analysis, variables that achieved significance at P\< 0.05 were selected to formulate a nomogram.

Conditions

Timeline

Start date
2004-04-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2022-03-10
Last updated
2022-03-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05274464. Inclusion in this directory is not an endorsement.